KVLQT1—a long QT syndrome gene
View Patent ↗The genomic structure including the sequence of the intron/exon junctions is disclosed for KVLQT1 and KCNE1 which are genes associated with long QT syndrome. Additional sequence data for the two genes ARE also disclosed. Also disclosed are newly found mutations in KVLQT1 which result in long QT syndrome. The intron/exon junction sequence data allow for the design of primer pairs to amplify and sequence across all of the exons of the two genes. This can be used to screen persons for the presence of mutations which cause long QT syndrome. Assays can be performed to screen persons for the presence of mutations in either the DNA or proteins. The DNA and proteins may also be used in assays to screen for drugs which will be useful in treating or preventing the occurrence of long QT syndrome.
1. A method for detecting a mutation that causes or is associated with long QT syndrome comprising amplifying any one of exons 1-16 of KVLQT1 such that the entire exon, and no other exon or portion thereof, is amplified, and analyzing the amplified exon for a mutation that causes or is associated with long QT syndrome.